XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock-based Compensation
6 Months Ended
Jun. 30, 2024
Stock-based Compensation [Abstract]  
Stock-Based Compensation
NOTE 8 – Stock-based Compensation


Prior to June 21, 2023, the Company issued stock-based compensation awards to its directors and officers under the 2018 Long Term Incentive Plan (“LTIP”) which allowed the grant of non-qualified and incentive stock options, stock appreciation rights, full value awards and cash incentive awards.  The maximum number of shares available to be awarded under the LTIP was 161,638 shares.


On June 21, 2023, stockholders approved an Amendment and Restatement of the 2018 Long Term Incentive Plan (“Amended and Restated LTIP”) which allows the issuance of 487,500 additional shares and brought the number of shares that may be issued under the Amended and Restated LTIP to 649,138 shares.



Stock-based compensation is recognized on a straight-line basis over the vesting period. During the three months ended June 30, 2024 and 2023, the Company recorded $38 thousand and $51 thousand of stock-based compensation expense, respectively.  During the six months ended June 30, 2024 and 2023, the Company recorded $115 thousand and $90 thousand of stock-based compensation expense, respectively. During the three months ended June 30, 2024 and 2023, the Company recorded $96 thousand and $0 thousand of director stock compensation expense, respectively, which was determined using the fair value of the stock on the dates of the awards. During the six months ended June 30, 2024 and 2023, the Company recorded $96 thousand and $95 thousand, respectively, of director stock compensation expense, which was determined using the fair value of the stock on the dates of the awards.



As of June 30, 2024, 269,111 shares had been awarded under the Amended and Restated LTIP and 380,027 shares were available to be awarded.  The following tables present stock award activity during the three and six months ended June 30, 2024 and 2023:


   
Three months ended
 
   
June 30, 2024
   
June 30, 2023
 
   
(In thousands)
 
Outstanding at the beginning of the period
   
225,047
     
37,922
 
Granted during period
   
19,832
     
92,700
 
Forfeited during period
   
(27,149
)
   
(977
)
Vested during period
   
(40,215
)
   
 
Outstanding at the end of the period
   
177,515
     
129,645
 


   
Six months ended
 
   
June 30, 2024
   
June 30, 2023
 
   
(In thousands)
 
Outstanding at the beginning of the period
   
111,723
     
52,953
 
Granted during period
   
145,890
     
101,930
 
Forfeited during period
   
(27,149
)
   
(1,360
)
Vested during period
   
(52,949
)
   
(23,878
)
Outstanding at the end of the period
   
177,515
     
129,645
 



No stock options were granted, exercised or expired during the three and six months ended June 30, 2024 or 2023. During the three and six months ended June 30, 2024, 18,750 stock options were forfeited.


Options outstanding and exercisable at June 30, 2024 were as follows:

Outstanding
   
Exercisable
 
Number
Outstanding
 
Weighted Average
Remaining
Contractual Life
 
Weighted
Average
Exercise Price
   
Aggregate
Intrinsic
Value
   
Number
Outstanding
   
Weighted
Average
Exercise Price
   
Aggregate
Intrinsic Value
 
 
12,500
 
1.65 years
 
$
12.96
   
$
     
12,500
   
$
12.96
   
$
 



The Company did not record any stock-based compensation expense related to stock options during the three and six months ended June 30, 2024 and 2023.



All common stock share amounts above have been retroactively adjusted, as applicable, for the 1-for-8 reverse stock split effective November 1, 2023.  See Note 1.